Two cross-reactive monoclonal antibodies recognize overlapping epitopes on Neisseria meningitidis factor H binding protein but have different functional properties

被引:32
作者
Faleri, Agnese [1 ]
Santini, Laura [1 ]
Brier, Sebastien [1 ]
Pansegrau, Werner [1 ]
Lo Surdo, Paola [1 ]
Scarselli, Maria [1 ]
Buricchi, Francesca [1 ]
Volpini, Gianfranco [1 ]
Genovese, Alessia [1 ]
van der Veen, Stijn [2 ]
Lea, Susan [2 ]
Tang, Christoph M. [2 ]
Savino, Silvana [1 ]
Pizza, Mariagrazia [1 ]
Finco, Oretta [1 ]
Norais, Nathalie [1 ]
Masignani, Vega [1 ]
机构
[1] Novartis Vaccines & Diagnost Srl, Res Ctr, I-53100 Siena, Italy
[2] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England
基金
英国惠康基金; 英国医学研究理事会;
关键词
mAb synergy; MenB vaccine; meningococcal antigen; hydrogen/deuterium exchange mass spectrometry; BACTERICIDAL ACTIVITY; SEROGROUP-B; PROTECTIVE ANTIGEN; VIRULENCE FACTOR; VACCINE; COMPLEMENT; RESPONSES; SURVIVAL; SEQUENCE; GNA1870;
D O I
10.1096/fj.13-239012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Factor H binding protein (fHbp) is one of the main antigens of the 4-component meningococcus B (4CMenB) multicomponent vaccine against disease caused by serogroup B Neisseria meningitidis (MenB). fHbp binds the complement down-regulating protein human factor H (hfH), thus resulting in immune evasion. fHbp exists in 3 variant groups with limited cross-protective responses. Previous studies have described the generation of monoclonal antibodies (mAbs) targeting variant-specific regions of fHbp. Here we report for the first time the functional characterization of two mAbs that recognize a wide panel of fHbp variants and subvariants on the MenB surface and that are able to inhibit fHbp binding to hfH. The antigenic regions targeted by the two mAbs were accurately mapped by hydrogen-deuterium exchange mass spectrometry (HDX-MS), revealing partially overlapping epitopes on the N terminus of fHbp. Furthermore, while none of the mAbs had bactericidal activity on its own, a synergistic effect was observed for each of them when tested by the human complement serum bactericidal activity (hSBA) assay in combination with a second nonbactericidal mAb. The bases underlying fHbp variant cross-reactivity, as well as inhibition of hfH binding and cooperativity effect observed for the two mAbs, are discussed in light of the mapped epitopes.-Faleri, A., Santini, L., Brier, S., Pansegrau, W., Lo Surdo, P., Scarselli, M., Buricchi, F., Volpini, G., Genovese, A., van der Veen, S., Lea, S., Tang, C. M., Savino, S., Pizza, M., Finco, O., Norais, N., Masignani, V. Two cross-reactive monoclonal antibodies recognize overlapping epitopes on Neisseria meningitidis factor H binding protein but have different functional properties.
引用
收藏
页码:1644 / 1653
页数:10
相关论文
共 42 条
[1]   Epitope mapping of a monoclonal antibody against human thrombin by R/D-exchange mass spectrometry reveals selection of a diverse sequence in a highly conserved protein [J].
Baerga-Ortiz, A ;
Hughes, CA ;
Mandell, JG ;
Komives, EA .
PROTEIN SCIENCE, 2002, 11 (06) :1300-1308
[2]   Genetic shifts of Neisseria meningitidis serogroup B antigens and the quest for a broadly cross-protective vaccine [J].
Bai, Xilian ;
Borrow, Ray .
EXPERT REVIEW OF VACCINES, 2010, 9 (10) :1203-1217
[3]   Fine antigenic specificity and cooperative bactericidal activity of monoclonal antibodies directed at the meningococcal vaccine candidate factor H-binding protein [J].
Beernink, Peter T. ;
Welsch, Jo Anne ;
Bar-Lev, Michal ;
Koeberling, Oliver ;
Comanducci, Maurizio ;
Granoff, Dan M. .
INFECTION AND IMMUNITY, 2008, 76 (09) :4232-4240
[4]   Bactericidal antibody responses induced by meningococcal recombinant chimeric factor H-binding protein vaccines [J].
Beernink, Peter T. ;
Granoff, Dan M. .
INFECTION AND IMMUNITY, 2008, 76 (06) :2568-2575
[5]   The modular architecture of meningococcal factor H-binding protein [J].
Beernink, Peter T. ;
Granoff, Dan M. .
MICROBIOLOGY-SGM, 2009, 155 :2873-2883
[6]   A region of the N-terminal domain of meningococcal factor H-binding protein that elicits bactericidal antibody across antigenic variant groups [J].
Beernink, Peter T. ;
LoPasso, Carla ;
Angiolillo, Antonella ;
Felici, Franco ;
Granoff, Dan .
MOLECULAR IMMUNOLOGY, 2009, 46 (8-9) :1647-1653
[7]   Interlaboratory standardization of the measurement of serum bactericidal activity by using human complement against meningococcal serogroup B, strain 44/76-SL, before and after vaccination with the Norwegian MenBvac outer membrane vesicle vaccine [J].
Borrow, R ;
Aaberge, IS ;
Santos, GF ;
Eudey, TL ;
Oster, P ;
Glennie, A ;
Findlow, J ;
Hoiby, EA ;
Rosenqvist, E ;
Balmer, P ;
Martin, D .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2005, 12 (08) :970-976
[8]   Structural Insight into the Mechanism of DNA-Binding Attenuation of the Neisserial Adhesin Repressor NadR by the Small Natural Ligand 4-Hydroxyphenylacetic Acid [J].
Brier, Sebastien ;
Fagnocchi, Luca ;
Donnarumma, Danilo ;
Scarselli, Maria ;
Rappuoli, Rino ;
Nissum, Mikkel ;
Delany, Isabel ;
Norais, Nathalie .
BIOCHEMISTRY, 2012, 51 (34) :6738-6752
[9]   Solution structure of the immunodominant domain of protective antigen GNA1870 of Neisseria meningitidis [J].
Cantini, F ;
Savino, S ;
Scarselli, M ;
Masignani, V ;
Pizza, M ;
Romagnoli, G ;
Swennen, E ;
Veggi, D ;
Banci, L ;
Rappuoli, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (11) :7220-7227
[10]   Solution Structure of the Factor H-binding Protein, a Survival Factor and Protective Antigen of Neisseria meningitidis [J].
Cantini, Francesca ;
Veggi, Daniele ;
Dragonetti, Sara ;
Savino, Silvana ;
Scarselli, Maria ;
Romagnoli, Giacomo ;
Pizza, Mariagrazia ;
Banci, Lucia ;
Rappuoli, Rino .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (14) :9022-9026